They found that mice injected with sertraline have doubled mean tumor weight accompanied by an increase in the expression of the Ki67 marker, hypothesizing that sertraline treatment can alter serotonin levels in the tumor microenvironment, leading to the activation of proliferation pathways [84]. The gene discussed is MKI67; the disease is neoplasm.